TH162432A - Triazolopyridine (TRIAZOLOPYRIDINE) which was replaced. And the use of such substances As a TTK inhibitor (SUBSTITUTE TRIAZOLOPYRIDINES AND THEIR USE AS TTK INHIBITORS) - Google Patents
Triazolopyridine (TRIAZOLOPYRIDINE) which was replaced. And the use of such substances As a TTK inhibitor (SUBSTITUTE TRIAZOLOPYRIDINES AND THEIR USE AS TTK INHIBITORS)Info
- Publication number
- TH162432A TH162432A TH1401003271A TH1401003271A TH162432A TH 162432 A TH162432 A TH 162432A TH 1401003271 A TH1401003271 A TH 1401003271A TH 1401003271 A TH1401003271 A TH 1401003271A TH 162432 A TH162432 A TH 162432A
- Authority
- TH
- Thailand
- Prior art keywords
- triazolopyridine
- ttk
- compounds
- substances
- replaced
- Prior art date
Links
- OVCXRBARSPBVMC-UHFFFAOYSA-N Triazolopyridine Chemical compound C=1N2C(C(C)C)=NN=C2C=CC=1C=1OC=NC=1C1=CC=C(F)C=C1 OVCXRBARSPBVMC-UHFFFAOYSA-N 0.000 title claims abstract 6
- 239000000126 substance Substances 0.000 title claims abstract 5
- 239000003112 inhibitor Substances 0.000 title 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000008523 triazolopyridines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 10
- 239000003814 drug Substances 0.000 claims abstract 4
- 229940079593 drugs Drugs 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 2
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Abstract
DC60 (13/08/57) การประดิษฐ์นี้เกี่ยวข้องกับสารประกอบไตรอะโซโลไพริดีน (triazolopyridine) ซึ่งถูกแทนที่ ตามสูตรทั่วไป (I) (สูตรเคมี) (I) โดยที่ R1, R2, R3, R4 และ R5 เป็นดังกำหนดในคำบรรยายและในข้อถือสิทธิ, วิธีการเตรียมสารประกอบดังกล่าว, องค์ประกอบทางเภสัชกรรมและยารวมซึ่งประกอบรวมด้วย สารประกอบดังกล่าว, การใช้สารประกอบดังกล่าวสำหรับการผลิตองค์ประกอบทางเภสัชกรรมเพื่อ การรักษาหรือการป้องกันโรค ตลอดจนสารมัธยันตร์ที่มีประโยชน์ในการเตรียมสารประกอบดังกล่าว : สิทธิบัตรยา DC60 (13/08/14) This invention relates to the compound triazolopyridine. (triazolopyridine) which is replaced According to the general formula (I) (chemical formula) (I) where R1, R2, R3, R4 and R5 are defined in the descriptions and in the claim, the method for the preparation of such compounds, the pharmaceutical and combined drug elements that comprise Included Such compounds, the use of such compounds for the manufacture of pharmaceutical components to Treatment or prevention of disease As well as substances that are useful in the preparation of such compounds: drug patents
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH162432A true TH162432A (en) | 2017-05-11 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TH162432A (en) | Triazolopyridine (TRIAZOLOPYRIDINE) which was replaced. And the use of such substances As a TTK inhibitor (SUBSTITUTE TRIAZOLOPYRIDINES AND THEIR USE AS TTK INHIBITORS) | |
| TH146336A (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
| TH146335A (en) | New derivatives of 1,2,3,4-tetrahydroquinoline useful for the treatment of diabetes. | |
| TH1701002063A (en) | Aldosteron Synthes inhibitors | |
| TH153195A (en) | Neprilisin inhibitor | |
| TH182770A (en) | Aldosteron Synthes inhibitors | |
| TH156811A (en) | Cancer-fighting pyridopyrazine by inhibiting FGFR kinase. | |
| TH154747A (en) | Heterocyclic compounds suitable for the treatment of hyperlipidemia. | |
| TH153190A (en) | Benzamide derivatives for inhibition of the inactivation of ABL1, ABL2 and BCR-ABL1. | |
| TH129182A (en) | Oxazine derivatives and their use in the treatment of disorders related to the nervous system. | |
| TH154776A (en) | TRPV1 Antagonists, including dihydroxy agents and their use. | |
| TH182678A (en) | Tetrahydroquinoline derivatives, bromodomain inhibitors | |
| TH147171A (en) | Halogen-alkyl-1,3 Oxacine as a BACE1 and / or BACE2 inhibitor | |
| TH153697A (en) | 2-oxo-1-pyrolidinyl derivatives Immidasothiazole (2-Oxo-1-pyrrolidinyl imidazothiadiazole derivative) | |
| TH145227A (en) | Salt 9E-15- (2-pyrrolidin-1-il-etoxi) -7,12,25-triaxa -19,21,24-triaca-tetracyclose (18.3 .1.1 (2,5) .1 (14,18)) hexacosa-1 (24), 2,4,9,14,16,18 (26), 20,22-nonaenzi Straight | |
| TH156226A (en) | Compounds and compositions as c-kit kinase inhibitors | |
| TH167241A (en) | Benzothiazolone Compounds (Benzothiazolone) | |
| TH106831A (en) | A compound containing one group of cyclobutoxies | |
| TH157676A (en) | Pyrazole compounds as SGLT1 inhibitors | |
| TH136968A (en) | Aminothiazine dioxide compounds (Iminothiazine Dioxide Compounds) as BACE inhibitors, constituents, and their use. | |
| TH162153A (en) | A replacement tricyclic compound for use as an FGFR inhibitor | |
| TH153174A (en) | Immidazopyridinone Compound | |
| TH1701001398A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller | |
| TH156221A (en) | 4- (8-methoxy-1 - ((1-methoxipropane-2-il) -2- (tetrahydro-2H-pyran-4-il) - 1H-imidaiso [4.5-C] -quinolin-7-il) -3,5-dimethyl isosazole And their use as a bromodomain inhibitor. | |
| TH174237A (en) | Hydroxyethylpyrolidine as a beta 3 adrenaline receptor modulator |